Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder

INTRODUCTION: Ketamine and its S-enantiomer esketamine are novel pharmacotherapeutic options for treatment resistant depression (TRD). There is growing evidence on the efficacy for other psychiatric disorders, including posttraumatic stress disorder (PTSD). It is hypothesized that psychotherapy may...

Descripción completa

Detalles Bibliográficos
Autores principales: Veraart, J.K.E., van Westenbrugge, M., van Wulfften Palthe, J.E., van der Meij, A., Schoevers, R.A., de Jong, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200841/
https://www.ncbi.nlm.nih.gov/pubmed/37223704
http://dx.doi.org/10.1016/j.heliyon.2023.e15883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200841/
https://www.ncbi.nlm.nih.gov/pubmed/37223704
http://dx.doi.org/10.1016/j.heliyon.2023.e15883

Ejemplares similares